Affordable Access

deepdyve-link
Publisher Website

Biomarker development in endometriosis.

Authors
  • Burney, Richard O
Type
Published Article
Journal
Scandinavian journal of clinical and laboratory investigation. Supplementum
Publication Date
Jan 01, 2014
Volume
244
Identifiers
DOI: 10.3109/00365513.2014.936692
PMID: 25083898
Source
Medline
Keywords
License
Unknown

Abstract

Endometriosis is a common gynecologic disorder histologically characterized by the displacement of endometrial tissue to extra-uterine locations. A significant cause of infertility and pelvic pain, the global socioeconomic burden of endometriosis is staggering. Laparoscopy remains the gold standard for the diagnosis of the condition. However, the invasive nature of surgery, coupled with the lack of a laboratory biomarker for the disease, results in a mean latency of 6-7 years from onset of symptoms to definitive diagnosis. Unfortunately, the delay in diagnosis may have significant consequences in terms of disease progression. The discovery of a sufficiently sensitive and specific biomarker for the non-surgical detection of endometriosis promises earlier diagnosis and prevention of deleterious sequelae, and remains a top research priority. The enigmatic pathophysiology of endometriosis presents unique challenges to biomarker development that are now well outlined. Within the past decade, significant advancements in understanding the molecular hallmarks of endometriosis have occurred, and promising biomarker candidates are emerging.

Report this publication

Statistics

Seen <100 times